RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, announces that discussions regarding a potential merger with Renexxion, Inc. (Renexxion) have been terminated. After signing a non-binding letter of intent in November 2024, both companies engaged in discussions to form a combined entity with an expanded therapeutic pipeline. However, key conditions necessary to finalize the transaction were not met within the required timeframe. As a result, both parties have mutually agreed to discontinue negotiations.
Read the full article: Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion //
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/relief-therapeutics-announces-conclusion-of-merger-discussions-with-re-996620